Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Study identifies characteristics that may constitute the MS prodrome
- Author:
- Doug Brunk
SAN DIEGO - Some neurologic health problems may be early signs of multiple sclerosis
News
Study spotlights body image dissatisfaction in pediatric IBD
- Author:
- Doug Brunk
Among pediatric IBD patients, risk factors for body image dissatisfaction include female gender, older age at diagnosis, and active disease.
News
High patient activation linked to clinical remission in IBD
- Author:
- Doug Brunk
LAS VEGAS – Patients’ education attainment may be related to activation level.
News
‘Real-world evidence’ used to compare agents for relapsing-remitting MS
- Author:
- Doug Brunk
SAN DIEGO – The comparative effectiveness of delayed-release dimethyl fumarate was analyzed against fingolimod and glatiramer acetate.
News
Switching RRMS patients to daclizumab beta appears safe
- Author:
- Doug Brunk
SAN DIEGO – A post hoc analysis from the DECIDE study sheds light on the efficacy of transitioning patients from glatiramer acetate to daclizumab...
Video
VIDEO: Efficacy of DMTs decreases with age
- Author:
- Doug Brunk
SAN DIEGO – A meta-analysis offers new insights into the age-dependent efficacy of multiple sclerosis treatments.
News
Many drugs in the pipeline for IBD treatment
- Author:
- Doug Brunk
Anti-integrins, anti-interleukins, Janus kinase inhibitors, and sphingosine-1–phosphate receptor 1 modulators are in the pipeline for both...
News
Ibudilast shows promise in progressive MS
- Author:
- Doug Brunk
SAN DIEGO – Imaging results proved favorable, and clinical endpoints will be forthcoming.
News
Study finds rising use of newer DMTs in pediatric-onset MS
- Author:
- Doug Brunk
Newer disease-modifying therapies often used in pediatric-onset MS patients appear to have short-term side effect profiles similar to those in...
News
‘Smoker’s paradox’ found in study of IBD patients
- Author:
- Doug Brunk
Smoking is more prevalent in Crohn’s disease patients than in patients with ulcerative colitis, according to a retrospective analysis of national...
News
Higher BMI linked to problems for IBD patients
- Author:
- Doug Brunk
LAS VEGAS – Higher BMI among IBD patients is independently associated with an increased risk of treatment failure and IBD-related surgery or...
News
Learn ‘four Ds’ approach to heart failure in diabetes
- Author:
- Doug Brunk
Heart failure in the presence of type 2 diabetes has a 5-year survival rate on par with some of the worst diseases.
News
Whatever the substance, adolescents’ abuse shares common links
- Author:
- Doug Brunk
In teens who are daily cigarettes smokers, use of alcohol, marijuana, and tobacco shares unique and common associations.
News
How to prioritize CVD reduction in type 2 diabetes
- Author:
- Doug Brunk
The paradigm of treating patients with type 2 diabetes should shift from a narrow focus on hemoglobin A1c control.
News
Delayed ileal pouch anal anastomosis creation linked to lower 30-day adverse events
- Author:
- Doug Brunk
LAS VEGAS – The surgical procedure of choice for many ulcerative colitis patients is total proctocolectomy with ileal pouch anal anastomosis...